Outcome of noncatheter-related thrombosis in children: Influence of underlying or coexisting factors

被引:47
作者
Gurgey, A [1 ]
Aslan, D [1 ]
机构
[1] Hacettepe Univ, Dept Pediat Hematol, TR-06100 Ankara, Turkey
关键词
catheter; thrombosis; factor V Leiden; protein C; protein S; antithrombin III; antiphospholipid antibodies; prothrombin; 20210A;
D O I
10.1097/00043426-200103000-00007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine the hereditary and nonhereditary risk factors contributing to the development of noncatheter-related thrombosis in children. Patients and Methods: Ninety-five children with noncatheter-related thrombosis from a single center were analyzed for clinical manifestations and outcome during a period of 3.5 years. Patients with thrombosis were evaluated for congenital and acquired risk factors, and patients were screened for factor V Leiden. prothrombin 20210A mutations, protein C, protein S, antithrombin III deficiencies, and antiphospholipid antibodies. Results: Twelve patients (12.5%) died of thrombosis that was associated with a nonmalignant underlying disorder, and 19 patients (20%) had significant complications, including amputation of extremities, epilepsy, hemiplegia, portal hypertension, recurrence of deep vein thrombosis, and postphlebitic syndrome. Two common mutations (factor V Leiden and prothrombin 20210A) were found in 32.5% of the patients with thrombosis. The most frequent underlying disorder was infection (68%). Ninety-three patients (98%) had one or more risk factors. Conclusions: The coexistence of an underlying disorder and the presence of predisposing factors such as infection and the factor V Leiden mutation may cause high rates: of death and complications in children with noncatheter-related thrombosis. The results of this study indicate that the underlying disorder and the site of thrombosis determine the rates of death and complications in children with thrombosis.
引用
收藏
页码:159 / 164
页数:6
相关论文
共 23 条
[1]   VENOUS THROMBOEMBOLIC COMPLICATIONS (VTE) IN CHILDREN - FIRST ANALYSES OF THE CANADIAN REGISTRY OF VTE [J].
ANDREW, M ;
DAVID, M ;
ADAMS, M ;
ALI, K ;
ANDERSON, R ;
BARNARD, D ;
BERNSTEIN, M ;
BRISSON, L ;
CAIRNEY, B ;
DESAI, D ;
GRANT, R ;
ISRAELS, S ;
JARDINE, L ;
LUKE, B ;
MASSICOTTE, P ;
SILVA, M .
BLOOD, 1994, 83 (05) :1251-1257
[2]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[3]  
Bonduel M, 1998, INT J PEDIAT HEM ONC, V5, P21
[4]   THE QUANTITATIVE ASSOCIATION OF PLASMA ENDOTOXIN, ANTITHROMBIN, PROTEIN-C, EXTRINSIC PATHWAY INHIBITOR AND FIBRINOPEPTIDE-A IN SYSTEMIC MENINGOCOCCAL DISEASE [J].
BRANDTZAEG, P ;
SANDSET, PM ;
JOO, GB ;
OVSTEBO, R ;
ABILDGAARD, U ;
KIERULF, P .
THROMBOSIS RESEARCH, 1989, 55 (04) :459-470
[5]  
Gurgey A, 1997, TURKISH J PEDIATR, V39, P313
[6]  
Gürgey A, 1998, AM J HEMATOL, V59, P179, DOI 10.1002/(SICI)1096-8652(199810)59:2<179::AID-AJH16>3.0.CO
[7]  
2-4
[8]   Clinical manifestations in thrombotic children with factor V Leiden mutation [J].
Gurgey, A .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1999, 16 (03) :233-237
[9]   Prevalence of the factor V Leiden mutation in children and neonates with thromboembolic disease [J].
Hagstrom, JN ;
Walter, J ;
Bluebond-Langner, R ;
Amatniek, JC ;
Manno, CS ;
High, KA .
JOURNAL OF PEDIATRICS, 1998, 133 (06) :777-781
[10]   Prothrombin G20210A gene mutation and further prothrombotic risk factors in childhood thrombophilia [J].
Junker, R ;
Koch, HG ;
Auberger, K ;
Münchow, N ;
Ehrenforth, S ;
Nowak-Göttl, U .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) :2568-2572